Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alshankyty, Ibraheem M"'
Autor:
Abdel-Gayoum, Abdelgayoum A., Al-Hassan, Abdelrahman A., Ginawi, Ibrahim A., Alshankyty, Ibraheem M.
Publikováno v:
In Toxicology Reports 2015 2:1327-1333
Autor:
Joseph, Chitra, Al-Izzi, Sara, Alsaleem, Mansour, Kurozumi, Sasagu, Toss, Michael, Arshad, Maariya, Goh, Fang Qin, Alshankyty, Ibraheem M, Ali, Simak, Ellis, Ian O, Mongan, Nigel P, Green, Andrew R, Rakha, Emad A
© 2019, The Author(s), under exclusive licence to Cancer Research UK. Background: Retinoid X Receptor Gamma (RXRG) is a member of the nuclear receptor superfamily and plays a role in tumour suppression. This study aims to explore the prognostic sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::83d3c48dd0db385759b0d219c89e703f
Autor:
Joseph C; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Al-Izzi S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Alsaleem M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Kurozumi S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Toss MS; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt., Arshad M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Goh FQ; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Alshankyty IM; Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia., Aleskandarany MA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt., Ali S; Faculty of Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Ellis IO; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Mongan NP; Cancer Biology and Translational Research, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA., Green AR; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Rakha EA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK. Emad.Rakha@nottingham.ac.uk.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt. Emad.Rakha@nottingham.ac.uk.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Oct; Vol. 121 (9), pp. 776-785. Date of Electronic Publication: 2019 Sep 27.